ATE238062T1 - Hemmung von hiv-infektion - Google Patents

Hemmung von hiv-infektion

Info

Publication number
ATE238062T1
ATE238062T1 AT93921439T AT93921439T ATE238062T1 AT E238062 T1 ATE238062 T1 AT E238062T1 AT 93921439 T AT93921439 T AT 93921439T AT 93921439 T AT93921439 T AT 93921439T AT E238062 T1 ATE238062 T1 AT E238062T1
Authority
AT
Austria
Prior art keywords
hiv infection
inhibition
slpi
prevention
methods
Prior art date
Application number
AT93921439T
Other languages
English (en)
Inventor
Stephen Eisenberg
Sharon M Wahl
Robert C Thompson
Original Assignee
Amgen Inc
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc, Us Gov Health & Human Serv filed Critical Amgen Inc
Application granted granted Critical
Publication of ATE238062T1 publication Critical patent/ATE238062T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • AIDS & HIV (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT93921439T 1992-09-09 1993-09-09 Hemmung von hiv-infektion ATE238062T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94336992A 1992-09-09 1992-09-09
PCT/US1993/008486 WO1994006454A2 (en) 1992-09-09 1993-09-09 Inhibitiion of retrovirus infection

Publications (1)

Publication Number Publication Date
ATE238062T1 true ATE238062T1 (de) 2003-05-15

Family

ID=25479533

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93921439T ATE238062T1 (de) 1992-09-09 1993-09-09 Hemmung von hiv-infektion

Country Status (23)

Country Link
EP (1) EP0666755B1 (de)
JP (2) JP3517238B2 (de)
KR (1) KR100273620B1 (de)
AT (1) ATE238062T1 (de)
AU (1) AU681350B2 (de)
CA (1) CA2141951C (de)
CZ (1) CZ286953B6 (de)
DE (1) DE69332904T2 (de)
DK (1) DK0666755T3 (de)
ES (1) ES2197153T3 (de)
FI (1) FI951078A7 (de)
HU (1) HU218892B (de)
NO (1) NO315546B1 (de)
NZ (1) NZ256246A (de)
OA (1) OA10133A (de)
PL (1) PL307864A1 (de)
PT (1) PT666755E (de)
RO (1) RO116164B1 (de)
RU (1) RU2126266C1 (de)
SG (1) SG48115A1 (de)
SK (1) SK281127B6 (de)
UA (1) UA41338C2 (de)
WO (1) WO1994006454A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI963753L (fi) * 1994-03-23 1996-09-20 Tokyo Tanabe Co Uusi lääke hengitysteiden virustaudin hoitamiseksi
AU6530696A (en) * 1995-07-24 1997-02-18 Tokyo Tanabe Company Limited Remedy for viral diseases
AU7508196A (en) 1995-11-13 1997-06-05 Gerard Voerman Anti-viral isolates obtainable from leeches
JP4562290B2 (ja) 1999-05-13 2010-10-13 独立行政法人科学技術振興機構 インテグラーゼｎ−末端領域を標的としたウイルス感染阻害剤
DE10101792B4 (de) * 2001-01-17 2004-03-18 Vivotec Biomedical Technologies Gmbh Verfahren zum Nachweis von Pankreaskarzinom oder chronischer Pankreatitis und Verwendung von Antikörpern
US8288439B2 (en) 2003-11-04 2012-10-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods and compositions for the inhibition of HIV-1 replication

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760130A (en) * 1984-12-06 1988-07-26 Synergen Biologicals, Inc. Serine protease inhibitors and methods for isolation of same
CA1340877C (en) * 1987-12-28 2000-01-18 Takashi Sugiyama Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology
JP2804979B2 (ja) * 1988-11-28 1998-09-30 日本ケミカルリサーチ株式会社 エイズ治療および阻害剤
CA2007083A1 (en) * 1989-01-09 1990-07-09 Nobuhiko Katunuma Pharmaceutical use of trypstatin
AU5940090A (en) * 1989-08-16 1991-04-03 Cetus Oncology Corporation Compositions for the inhibition of protein hormone formation and uses thereof
AU6975591A (en) * 1989-12-18 1991-07-18 Transgene S.A. Pharmaceutical composition for treating or preventing retroviral infections
GR1001044B (el) * 1991-06-03 1993-04-28 Logothetou Rella Eleni Μηχανισμός διή?ησης νεοπλασματικών κυττάρων και η χρήση του αναστολέα της Ca2+ -εξαρτώμενης ουδέτερης πρωτεάσης για την παρασκευή φαρμακευτικών αντικαρκινικών συν?έσεων.

Also Published As

Publication number Publication date
WO1994006454A3 (en) 1994-08-18
EP0666755B1 (de) 2003-04-23
CZ55995A3 (en) 1996-01-17
CZ286953B6 (en) 2000-08-16
JPH08505042A (ja) 1996-06-04
NZ256246A (en) 1997-08-22
HU9500682D0 (en) 1995-04-28
SG48115A1 (en) 1998-04-17
DE69332904D1 (de) 2003-05-28
KR100273620B1 (ko) 2000-12-15
SK29795A3 (en) 1997-02-05
ES2197153T3 (es) 2004-01-01
SK281127B6 (sk) 2000-12-11
RU95109909A (ru) 1997-03-27
PT666755E (pt) 2003-09-30
CA2141951A1 (en) 1994-03-31
FI951078L (fi) 1995-03-08
DK0666755T3 (da) 2003-08-04
UA41338C2 (uk) 2001-09-17
NO950897L (no) 1995-03-08
RO116164B1 (ro) 2000-11-30
NO950897D0 (no) 1995-03-08
JP3517238B2 (ja) 2004-04-12
AU681350B2 (en) 1997-08-28
RU2126266C1 (ru) 1999-02-20
NO315546B1 (no) 2003-09-22
EP0666755A1 (de) 1995-08-16
FI951078A0 (fi) 1995-03-08
JP2004002455A (ja) 2004-01-08
AU4853093A (en) 1994-04-12
OA10133A (en) 1996-12-18
DE69332904T2 (de) 2003-11-06
WO1994006454A2 (en) 1994-03-31
FI951078A7 (fi) 1995-03-08
HU218892B (hu) 2000-12-28
HUT75126A (en) 1997-04-28
PL307864A1 (en) 1995-06-26
CA2141951C (en) 2007-04-24
KR950703357A (ko) 1995-09-20

Similar Documents

Publication Publication Date Title
RU95106823A (ru) Сукциноиламиногидроксиэтиламиносульфонамиды, фармацевтическая композиция, способ ингибирования ретровирусной протеазы, способ лечения ретровирусной инфекции способ лечения спида
MX9706913A (es) Compuestos de bis-aminacido-hidroxietilamina-sulfonamida inhibidoresde proteasan retroviral, composiciones que los contienen y ek uso de los mismos.
DK0951473T3 (da) Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette
NO974148L (no) Aminosyrehydroksyetylaminosulfonamid retrovirale proteaseinhibitorer
MX9706947A (es) Inhibidores de proteasa retroviral de sulfonilalcanoilamino-hidroxietilamino-sulfonamida y uso de los mismos.
NO983688L (no) Serin-protease-inhibitorer
ATE229033T1 (de) Heterocyclocarbonyl-aminosäure-hydroxyethylamin - sulfonamid inhibitoren retroviraler proteasen
NO962017L (no) 5,6-Dihydropyron - derivater som protease-inhibitorer og antivirus-midler
NO983991L (no) Serin-protease-inhibitorer
MD960172A (en) 5,6-dihydropyrone derivatives as proteaze inhibitors and antiviral agents
NO934720L (no) Nye HIV protease inhibitorer
ATE238062T1 (de) Hemmung von hiv-infektion
RU95106624A (ru) Гидроксиэтиламиносульфонамиды, промежуточные соединения, фармацевтическая композиция, способ ингибирования ретровирусных протеаз, способ лечения ретровирусных инфекций, способ лечения спида
MX9304351A (es) Inhibidores de proteasas de aminodiol y composiciones farmaceuticas que los incluyen.
MX9706912A (es) Inhibidores de protesa retroviral de sulfonamida de hidroxietilamino de amino acido y uso de los mismos.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0666755

Country of ref document: EP

REN Ceased due to non-payment of the annual fee